C4 Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
CCCC
CUSIP
12529R107
Type
Equity
Class
COM STK
Num filings
109
Total reported value, excl. options
$153 M
Manager Report Date Value ($000) Shares Option Type